Editor’s Note: This article is a reprint. It was originally published February 14, 2018. Environmental pollution is a tremendous concern, and the sources of toxic pollution are many. One source that has managed to skirt below the radar is the drug industry.1,2,3,4 In 2016, the nonprofit foundation Changing Markets issued a report on “Impacts of… Read More »
Advertisement Continue reading the main story Supported by Continue reading the main story Severe Covid Is More Often Fatal in Africa Than in Other Regions Inadequate treatment for critically ill patients contributed to higher death rates in Africa, compared to other parts of the world, a study found. Treating a Covid patient in Mekele, Ethiopia,… Read More »
FDA Approves Zegalogue (dasiglucagon) Injection for the Treatment of Severe Hypoglycemia in People with Diabetes Copenhagen, DK and Boston, MA, U.S. March 22, 2021 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078,) a biotechnology company aspiring to deliver innovation with novel peptide therapeutics, announced today that the U.S. Food and Drug Administration (FDA) has approved Zegalogue® (dasiglucagon)… Read More »
Article content continued Conley was more transparent Sunday, indicating that the president had twice had episodes of falling blood-oxygen levels. Those levels are important because they indicate how much oxygen the lungs are transferring into the blood supply, crucial for keeping the body’s various systems functioning. The first time oxygenation dropped, late Friday morning at… Read More »
Early data from a clinical study suggest that blocking the Bruton tyrosine kinase (BTK) protein provided clinical benefit to a small group of patients with severe COVID-19. Researchers observed that the off-label use of the cancer drug acalabrutinib, a BTK inhibitor that is approved to treat several blood cancers, was associated with reduced respiratory distress… Read More »